117 related articles for article (PubMed ID: 10764960)
21. Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings.
Chiu S; Paulose CS; Mishra RK
Peptides; 1981; 2(1):105-11. PubMed ID: 6113579
[TBL] [Abstract][Full Text] [Related]
22. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens.
Hussain N; Flumerfelt BA; Rajakumar N
Neuroscience; 2001; 102(2):391-9. PubMed ID: 11166125
[TBL] [Abstract][Full Text] [Related]
23. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
Bhargava HN
Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
[TBL] [Abstract][Full Text] [Related]
24. Muscarinic, adenosine A(2) and histamine H(3) receptor modulation of haloperidol-induced c-fos expression in the striatum and nucleus accumbens.
Hussain N; Flumerfelt BA; Rajakumar N
Neuroscience; 2002; 112(2):427-38. PubMed ID: 12044460
[TBL] [Abstract][Full Text] [Related]
25. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
[TBL] [Abstract][Full Text] [Related]
26. Clozapine antagonizes the induction of striatal Fos expression by typical neuroleptics.
Wirtshafter D
Eur J Pharmacol; 1998 Oct; 358(3):R1-3. PubMed ID: 9822897
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine.
Nguyen TV; Kosofsky BE; Birnbaum R; Cohen BM; Hyman SE
Proc Natl Acad Sci U S A; 1992 May; 89(10):4270-4. PubMed ID: 1374894
[TBL] [Abstract][Full Text] [Related]
28. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat.
Kostrzewa RM; Saleh MI
Neuropharmacology; 1989 Aug; 28(8):805-10. PubMed ID: 2571103
[TBL] [Abstract][Full Text] [Related]
30. Modulation of CNS dopamine receptors by peptides.
Mishra RK
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):437-42. PubMed ID: 6141599
[TBL] [Abstract][Full Text] [Related]
31. Are the pharmacological effects of L-prolyl-L-leucyl-glycinamide (PLG) mediated through specific receptor mechanisms?
Chiu S; Wong YW; Wan YP; Chiu P; Mishra RK
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):739-42. PubMed ID: 6141616
[TBL] [Abstract][Full Text] [Related]
32. Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine.
Fujimura M; Hashimoto K; Yamagami K
Eur J Pharmacol; 2000 Jun; 398(1):1-10. PubMed ID: 10856442
[TBL] [Abstract][Full Text] [Related]
33. [Induction by neuroleptics of certain genes in the central nervous system].
Rogue P; Vincendon G
Ann Med Psychol (Paris); 1992; 150(2-3):124-6. PubMed ID: 1343505
[TBL] [Abstract][Full Text] [Related]
34. The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum.
Ziólkowska B; Höllt V
Neurosci Lett; 1993 Jun; 156(1-2):39-42. PubMed ID: 8414186
[TBL] [Abstract][Full Text] [Related]
35. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
Robertson GS; Fibiger HC
Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
[TBL] [Abstract][Full Text] [Related]
36. Contrasting effects of SM-9018, a potential atypical antipsychotic, and haloperidol on c-fos mRNA expression in the rat striatum.
Ishibashi T; Ikeda K; Ishida K; Yasui J; Tojima R; Nakamura M; Ohno Y
Eur J Pharmacol; 1996 May; 303(3):247-51. PubMed ID: 8813576
[TBL] [Abstract][Full Text] [Related]
37. C-fos mediates antipsychotic-induced neurotensin gene expression in the rodent striatum.
Robertson GS; Tetzlaff W; Bedard A; St-Jean M; Wigle N
Neuroscience; 1995 Jul; 67(2):325-44. PubMed ID: 7675173
[TBL] [Abstract][Full Text] [Related]
38. Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice.
Pardo M; López-Cruz L; Valverde O; Ledent C; Baqi Y; Müller CE; Salamone JD; Correa M
Behav Brain Res; 2013 Jun; 247():217-26. PubMed ID: 23557694
[TBL] [Abstract][Full Text] [Related]
39. The KCNQ channel activator retigabine blocks haloperidol-induced c-Fos expression in the striatum of the rat.
Mikkelsen JD
Neurosci Lett; 2004 May; 362(3):240-3. PubMed ID: 15158023
[TBL] [Abstract][Full Text] [Related]
40. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine.
Werme M; Ringholm A; Olson L; Brené S
Brain Res; 2000 Apr; 863(1-2):112-9. PubMed ID: 10773199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
